Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study unconfirmed

Story checked

Blood proteins could reveal clues to prostate cancer risk more than a decade before diagnosis (opens in a new tab)

medicalxpress.com · 2026-10-21

Short answerEvidenceSource

Short answer

Source study unconfirmed

Study not confirmed.

The search did not establish a source study for this article. Its claims remain unverified; this does not mean they are incorrect.

15 candidate papersExplore the search results

These papers were considered as possible sources, but none could be confirmed as the study behind this story.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

No single source study could be confirmed.

The search identified related research but did not establish a single source study. Related papers are provided for context, not as verification of the article's claims.

View article claims
3

Search result

Source study unconfirmed.

The search identified related research but did not establish a single source study. Related papers are provided for context, not as verification of the article's claims.

Source paper

Source layer

The paper behind the story

The source record for this check.

The research anchor for the report.

  • Also referencedpresented as the new finding

    Circulating immune and cancer driver gene biomarkers precede prostate cancer diagnosis by over ten years

    Publisher (opens in a new tab)
The literature search

15 candidate papers

Studies identified during the search

These papers appeared in the search for the story’s source. None was confirmed as a direct match. Inclusion here does not mean a paper supports or contradicts the story, or that its full text was reviewed.

Show 11 more search results
Then inspect each claim

Evidence layer

Claim by claim

The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.

Claim 1 of 5Not checkedProteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study led by researchers at Oxford Population Health.View evidenceHide evidence

As statednew study; future risk; including aggressive disease

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 2 of 5Not checkedThe study analyzed blood samples from 982 men who later developed prostate cancer and 1,573 randomly selected men from EPIC, measured more than 6,000 proteins, and followed participants for around 16 years.View evidenceHide evidence

As stated982 cases; 1,573 controls; >6,000 proteins; ~16 years follow-up

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 3 of 5Not checkedTwelve proteins were linked to prostate cancer diagnosed more than 15 years after blood collection, and seven proteins were linked to aggressive prostate cancer; ANKRD1 was said to be consistently linked to several serious forms of disease.View evidenceHide evidence

As stated12 proteins; 7 proteins; more than 15 years; around a decade later

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 4 of 5Not checkedThe article says blood levels of proteins produced by known prostate cancer driver genes, including ERBB3, KRAS and NRAS, were particularly linked to aggressive prostate cancer diagnosed around a decade later.View evidenceHide evidence

As statedaround a decade later

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 5 of 5Not checkedThe researchers said several findings were supported by validation analyses, but the proteins are not yet suitable for clinical testing and further studies are needed to see whether they improve prediction of clinically significant prostate cancer.View evidenceHide evidence

As statednot yet suitable for clinical tests

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Finally, the search trail

Method layer

Study not confirmed.

The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.

Search results

Candidate papers, not confirmed sources.

PubMed, Crossref, Europe PMC · 15 candidate papers

Candidate

Prediagnostic genetic stratification for aggressive prostate cancer—is the puzzle for genetic variants gaining shape?

Translational Cancer Research · 2018 · Crossref

Source (opens in a new tab)

Explore all search results